Lawrence Karsh, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    FKD
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Consultant or Advisor (General Urology)
    Ineligible company:
    Swan Valley Medical
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Vaxiion
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Investment Interest (Oncology)
    Ineligible company:
    3D Biopsy
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Nymox
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Precision Biopsy
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    OPKO
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Precision Med
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Augmenix
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Myriad Genetics
    Date added:
    Date updated:
    09/14/2023

Pages

Return to The Changing Face of Advanced Prostate Cancer 2022 Webcast (2022)